Definition: GHRH (growth hormone-releasing hormone, also called GRF) is a hormone made in the hypothalamus, part of the brain. It acts on the pituitary to make and release growth hormone in pulses. A GHRH analog is a made-up version that switches on the same receptor, such as tesamorelin.
The Egrifta SV label describes GHRH as a hypothalamic peptide that acts on the pituitary to stimulate the synthesis and pulsatile release of growth hormone, which is both anabolic and lipolytic. Tesamorelin is built on the 44 amino acid sequence of human GRF with a small chain added at one end.
GHRH is one of two routes to GH release. The other runs through the receptor for ghrelin, which GHRPs use. See growth hormone secretagogue for both side by side.
Tesamorelin vs CJC-1295
Tesamorelin is FDA approved (Egrifta SV) for reducing excess belly fat in adults with HIV and lipodystrophy. We found no FDA label for CJC-1295; its human data come from small, short studies.
The Egrifta SV label says it raises IGF-1 and asks for IGF-1 levels to be monitored. Logging lab dates next to dose history makes those checks easier to read.
Read more on Dose Track: Tesamorelin guide · CJC-1295 guide · Sermorelin guide